Skip to main content
. 2023 Jun 6;14:1142680. doi: 10.3389/fphar.2023.1142680

FIGURE 4.

FIGURE 4

Approvals per month in psychiatric indications with >100 approvals. Approvals over time for anxiety [(A), n = 67,095]; sleep disorder [(B), n = 11,202)], insomnia [(C), n = 6,877); post-traumatic stress disorder [PTSD; (D), n = 5,799]; depression [(E), n = 3,247]; autism spectrum disorder [ASD; (F), n = 2,206]; attention deficit hyperactivity disorder [ADHD; (G), n = 2,078]; mood disorder [(H), n = 736]; Alzheimer’s disease [(I), n = 272]; restless leg syndrome [RLS; (J), n = 239]; bipolar disorder [(K), n = 212]; Tourette’s syndrome [(L), n = 163]; unspecified dementia [(M), n = 132]; behavior disorder [(N), n = 131]; cannabis use disorder [(O), n = 117]. Solid lines represent the best fit, with shading depicting standard error of the mean (SEM).